Gossamer Bio (NASDAQ:GOSS) reported quarterly losses of $(0.59) per share which beat the analyst consensus estimate of $(0.62) by 4.84 percent. This is a 20.27 percent increase over losses of $(0.74) per share from the same period last year.
Toronto Weed Producer Announces Successful Bidder For Sale And Investment Process
Aleafia Health Inc. (OTCQB: ALEAF) (TSX: AH) announced on Thursday that Red White & Bloom Brands Inc.